follow us:Google+ FacebookLinkedInTwitterRSS Feeds

advertisement

Cyclacel announces sale of four patents to Celgene, dismissal of litigation

By

Back to Top Comments Email Print

Latest News

advertisement

Cyclacel Pharmaceuticals Inc., in Berkeley Heights, announced today it will sell Celgene Corp., in Summit, four Cyclacel-owned patents in a $5.5 million deal.

According to an announcement, as a result of the agreement, Cyclacel and Celgene have filed a joint stipulation and order for dismissal requesting the court enter an order dismissing a patent litigation dispute between the companies.

Share This Story On:

Write to the Editorial Department at editorial@njbiz.com

advertisement

Comments


Be the first to comment.



Please note: All comments will be reviewed and may take up to 24 hours to appear on the site.

Post Comment
     View Comment Policy

Advanced search
Sponsored by
advertisement
  
  
advertisement
  
  
advertisement
Back to Top